Ormalvi Alternatives Compared
Ormalvi (dichlorphenamide) | Acetazolamide | Keveyis (dichlorphenamide) |
|
---|
Ormalvi (dichlorphenamide) | Acetazolamide | Keveyis (dichlorphenamide) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Hypokalemic Periodic Paralysis, Primary Periodic Paralysis, Hyperkalemic Periodic Paralysis. Ormalvi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma, Hydrocephalus, Edema, Epilepsy, Hypokalemic Periodic Paralysis, Mountain Sickness / Altitude Sickness, Pseudotumor Cerebri, Seizure Prevention, Seizures. Acetazolamide may... View more |
Prescription only
Prescribed for Hypokalemic Periodic Paralysis, Primary Periodic Paralysis, Hyperkalemic Periodic Paralysis. Keveyis may also be used for purposes not listed in this medication guide. |
Related suggestions Hypokalemic Periodic Paralysis
|
|||||||||||||||||||||||
More about (dichlorphenamide) | More about Acetazolamide | More about Keveyis (dichlorphenamide) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Be the first to share your experience with this drug. |
Acetazolamide has an average rating of 6.4 out of 10 from a total of 192 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 26% reported a negative effect. |
Keveyis has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Ormalvi side effects |
View all Acetazolamide side effects |
View all Keveyis side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
None |
||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic approved |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Ormalvi prices |
View all Acetazolamide prices |
View all Keveyis prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other dichlorphenamide brands include: Keveyis |
N/A |
Other dichlorphenamide brands include: Ormalvi | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
4 hours |
N/A |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 230 drugs are known to interact with Ormalvi:
|
A total of 263 drugs are known to interact with Acetazolamide:
|
A total of 230 drugs are known to interact with Keveyis:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
July 27, 1953 |
July 22, 1958 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.